公司概覽
業務類別 Biotechnology
業務概覽 Inventiva SA is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases with unmet medical needs.
公司地址 50 rue de Dijon, Daix, FRA, 21121
電話號碼 +33 380447500
傳真號碼 --
公司網頁 https://www.inventivapharma.com
員工數量 77
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Dr. Jason A. Campagna, M.D.,PhD President, Research and Development and Chief Medical Officer -- 08/04/2026
Mr. Jean Volatier Chief Financial Officer and Deputy General Manager 美元 212.92K 08/04/2026
Mr. Andrew Obenshain Chief Executive Officer -- 08/04/2026
Ms. Martine Zimmermann, Pharm.D. Executive Vice President, Regulatory Affairs and Quality Assurance 美元 149.50K 08/04/2026
 
董事會成員
董事會 職務 更新日期
Dr. Srinivas Akkaraju, M.D.,PhD Independent Director 08/04/2026
Dr. Mark Pruzanski, M.D. Chairman of the Board 08/04/2026
Dr. Annick Schwebig Independent Director 08/04/2026
Mr. G. Andre Turenne Independent Director 08/04/2026
Mr. Heinz Christoph Maeusli Independent Director 08/04/2026
Ms. Renee Aguiar-Lucander Independent Director 08/04/2026
 
所屬ETF (更新日期: 24/10/2026 02:31)
代號 名稱 佔比% ▼ 持有日期
HQLabrdn Life Sciences Investors0.68%30/09/2026
THWabrdn World Healthcare0.66%30/09/2026
SURISimplify Propel Opportunities ETF0.13%30/09/2026
MEDIHarbor Health Care ETF0.01%30/09/2026
APIEActivePassive International Equity ETF0.01%30/09/2026
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.